Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Transcarent

Explore full profile

New consumer-directed health and care platform for employees of self-insured employers and their families

San Francisco, United StatesFounded 2020Health Tech & Medtech
Valuation $1–2.5B Last recorded · 2026
Revenue $100–500M Latest reported FY
Headcount 500–1k Current team size
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Transcarent and the history behind them.

At a glance

Founded
2020
Headquarters
San Francisco, United States
Sector
Health Tech & Medtech
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Latest news

Press, funding announcements and product moves mentioning Transcarent.

See all news

Investors

17 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

Series B and later13 investors entered at this stage

  • Merck Global Health Innovation Fund
  • Intermountain Healthcare
  • Kleiner Perkins
  • Ally Bridge Group
  • Kinnevik
  • Rush University Medical Center
  • Memorial Hermann Health System
  • Human Capital
  • Threshold Ventures
  • GreatPoint Ventures
  • Leaps by Bayer
  • Geodesic Capital
  • Northwell Health
Employees mapped 836 incl. 14 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 9 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇺🇸 United States97.1%
🇨🇿 Czech Republic0.9%
🇲🇽 Mexico0.8%
🇷🇸 Serbia0.5%
🇨🇦 Canada0.5%
Top 5 of 6 shown
Web traffic by country
18K monthly visits
across markets
🇺🇸 United States90%
🇮🇳 India3.9%
🇵🇭 Philippines2.8%
🇨🇦 Canada2.2%
Top 4 markets shown

Patents

Estimated portfolio value
$2M

7 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Transcarent was the backer or acquirer, 2020–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Transcarent's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Transcarent deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Transcarent's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Transcarent on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Transcarent on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.